CORRELATION OF CA 15.3 LEVELS WITH METASTASIS IN BREAST CANCER-Reference-Cited by-同舟云学术

CORRELATION OF CA 15.3 LEVELS WITH METASTASIS IN BREAST CANCER

Published:2023-09-07 Issue: Volume: Page:42-44
ISSN:2455-3891
Container-title:Asian Journal of Pharmaceutical and Clinical Research
language:
Short-container-title:Asian J Pharm Clin Res

Author:

KARTHIKHAEYAN TR ,ASWIN KARTHIK PERIASAMY ,ANKITKUMAR SHARMA

Abstract

Objectives: The objective is to measure the serum levels of Cancer Antigen CA 15.3 in breast cancer patients with metastasis and without metastasis and compare the mean values between them. The study investigated the correlation between CA 15.3 levels and metastasis in breast cancer. Methods: The study was conducted with 45 female patients in a tertiary care center in India, and metastatic evaluation was done using positron emission tomography–computed tomography. Results: The results indicated that CA 15.3 levels were significantly higher in the metastatic group compared to the non-metastatic group. Conclusion: CA 15.3 has the potential as a diagnostic tool for early detection of metastases in breast cancer patients.

Publisher

Innovare Academic Sciences Pvt Ltd

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference6 articles.

1. Schwartz S, Brunicardi F. Schwartz’s Principles of Surgery. New York: McGraw-Hill Medical; 2010.

2. Duffy MJ, Shering S, Sherry F, McDermott E, O’Higgins N. CA 15-3: A prognostic marker in breast cancer. Int J Biol Markers 2000;15:330-3. doi: 10.1177/172460080001500410, PMID 11192829

3. Shao Y, Sun X, He Y, Liu C, Liu H. Elevated levels of serum tumor markers CEA and CA153 are prognostic parameters for different molecular subtypes of breast cancer. PLoS One 2015;10:e0133830.

4. Shering SG, Sherry F, McDermott EW, O’Higgins NJ, Duffy MJ. Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinoma. Cancer 1998;83:2521-7. doi: 10.1002/(SICI)1097- 0142(19981215)83:12<2521:AID-CNCR17>3.0.CO;2-A, PMID 9874458

5. Moazzezy N, Farahany TZ, Oloomi M, Bouzari S. Relationship between preoperative serum CA15-3 and CEA levels and clinicopathological parameters in breast cancer. Asian Pac J Cancer Prev 2014;15:1685-8. doi: 10.7314/apjcp.2014.15.4.1685, PMID 24641390

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A REVIEW OF NANOPARTICLE INNOVATIONS IN CANCER THERAPY: IMPLICATIONS, TARGETING MECHANISMS AND CLINICAL PROSPECTS;International Journal of Applied Pharmaceutics;2024-05-07